Company Description
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V.
site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers.
The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs.
The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms.
The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce.
Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
| Country | United States |
| Founded | 2023 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 22,000 |
| CEO | Bryan Hanson |
Contact Details
Address: 1750 Yankee Doodle Road Eagan, Minnesota 55121 United States | |
| Website | solventum.com |
Stock Details
| Ticker Symbol | SOLV |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001964738 |
| CUSIP Number | 83444M101 |
| ISIN Number | US83444M1018 |
| Employer ID | 92-2008841 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Bryan C. Hanson | Chief Executive Officer and Director |
| Wayde D. McMillan | Chief Financial Officer |
| Amy Landucci | Chief Information and Digital Officer |
| Tammy L. Gomez | Chief Human Resources Officer |
| Mary T. Wilcox | Senior Vice President, Corporate Controller and Chief Accounting Officer |
| Amy Wakeham | Senior Vice President of Investor Relations and External Finance Communications |
| Marcela A. Kirberger | Chief Corporate Legal Affairs Officer and Corporate Secretary |
| Kate Dobbs | Chief Communications and Corporate Marketing Officer |
| Rachel H. Ellingson | Chief Strategy and Corporate Development Officer |
| Paul S. Harrington | Chief Supply Chain Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 27, 2026 | 10-K | Annual Report |
| Feb 26, 2026 | 8-K | Current Report |
| Jan 27, 2026 | SCHEDULE 13G/A | Filing |
| Dec 16, 2025 | 8-K | Current Report |
| Nov 13, 2025 | SCHEDULE 13G/A | Filing |
| Nov 6, 2025 | 10-Q | Quarterly Report |
| Nov 6, 2025 | 8-K | Current Report |
| Oct 21, 2025 | 8-K | Current Report |
| Sep 8, 2025 | 8-K | Current Report |
| Sep 2, 2025 | 8-K | Current Report |